Phillips Medisize Corp. based in Hudson, Wisconsin, USA, celebrates its 50th year of continuous production in 2014 with the milestone marking the company’s ongoing involvement in the high growth medical and specialty commercial markets.
Matt Jennings, President and CEO, stated, “The past fifty years were built on the tried and true principles of building partnerships with our customers based around quality, innovation and service. We made these partnerships work by investing in our employees, processes, facilities and equipment which created a world class outsource design, development and manufacturing organisation. This organisation has allowed our customers to integrate their product designs with advanced moulding technologies and automated assembly, within a robust quality system.”
“This milestone also marks the company’s ongoing involvement in the high growth medical and specialty commercial markets serving our customers worldwide. We look forward to our next 50 years of operation by recommitting ourselves to the timeless principles of quality, service and innovation by continuing to invest in our people, processes and facilities,” stated Jennings.
Phillips Medisize introduced Metal Injection Moulding technology at the Menomonie plant in Wisconsin in 1996 followed two years later with magnesium injection moulding at the same site. MIM parts produced by the company are extensively used in medical devices as well as in firearms and other applications.
The company has annual group sales of over $500 million with 75% of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging, and diagnostic products such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components. The company employs over 3,100 people in 14 facilities throughout the United States, Europe, Mexico and China.